ARCHIVES

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors

September 15, 1995

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

Letter In Response To Hadley; RFA Available

July 7, 1995

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013